Juvenile Diabetes
8
0
1
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
60%
3 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (8)
PROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)
MEtabolic and Renal Effects of AutoMAted Insulin Delivery Systems in Youth With Type 1 Diabetes Mellitus
Control of Renal Oxygen Consumption, Mitochondrial Dysfunction, and Insulin Resistance
Diamyd Administered Into Lymph Nodes in Combination With Vitamin D in Type 1 Diabetes
Atherosclerotic Cardiovascular Risk in Childhood and Teen-age Onset Diabetes
Copeptin in Adolescent Participants With Type 1 Diabetes and Early Renal Hemodynamic Function
Evaluation of Coffee Therapy for Improvement of Renal Oxygenation
Azithromycin Insulin Diet Intervention Trial in Type 1 Diabetes